The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lower-dosing ponatinib in pre-treated GIST: Results of the POETIG phase II trial.
 
Johanna Falkenhorst
Travel, Accommodations, Expenses - Lilly; PharmaMar
 
Rainer Hamacher
Honoraria - Lilly
Travel, Accommodations, Expenses - Lilly; Novartis; PharmaMar
 
Peter Reichardt
Honoraria - Amgen; Bayer; Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Clinigen Group; Deciphera; Lilly; Novartis; Pfizer; PharmaMar; Roche
Research Funding - Novartis (Inst)
 
Philipp Ivanyi
No Relationships to Disclose
 
Bernd Kasper
Honoraria - Bayer; Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Clinigen Group; Eisai; Lilly; Roche; SpringWorks Therapeutics
Research Funding - PharmaMar
Travel, Accommodations, Expenses - Lilly; PharmaMar
 
Peter Hohenberger
Honoraria - Boehringer Ingelheim; Lilly; Pfizer; Roche
Consulting or Advisory Role - Lilly; Nanobiotix; Pfizer
Research Funding - Novartis; Siemens Healthcare Diagnostics (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Barbara Hermes
Research Funding - AstraZeneca (Inst); Bayer Health (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); PharmaMar (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Lilly; PharmaMar
 
Karina Kostbade
No Relationships to Disclose
 
Daniel Pink
Consulting or Advisory Role - Clinigen Group; Lilly; Roche
Research Funding - Clinigen Group; Lilly; Novartis; PharmaMar; Roche
 
Heiko Sülberg
No Relationships to Disclose
 
Martin Metzenmacher
Honoraria - MSD; Roche; Takeda
Consulting or Advisory Role - MSD; Roche; Takeda
Expert Testimony - MSD; Roche; Takeda
 
Martina Crysandt
Honoraria - Novartis
Travel, Accommodations, Expenses - Amgen; Celgene; Gilead Sciences
 
Sebastian Bauer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer; Pharmamar
Consulting or Advisory Role - ADC Therapeutics; Bayer; Blueprint Medicines; Daiichi Sankyo; Deciphera; Exelixis; Janssen-Cilag; Janssen-Cilag; Lilly; Nanobiotix
Research Funding - Blueprint Medicines; Incyte (Inst); Novartis
Travel, Accommodations, Expenses - Pharmamar